Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Researchers from Kyushu University publish new studies and findings in the area of cancer vaccines
June 17th, 2009
According to a study from Fukuoka, Japan, "Pancreatic cancer is one of Most fatal human cancers, with a 5-year survival rate <5%. Although new chemotherapies have been pancreatic cancer, the outcome is still poor." "Here, we retrospectively analyzed the outcome of immunotherapy in pancreatic cancer patients and revealed the potential immunotherapy in advanced pancreatic cancer treatment. Seventeen pancreatic cancer patients underwent immunotherapy in the Kyushu University an.! the Yakuin CA Clinic. Six patient, had postoperative recurrence, 11 were diagnosed as inoperable because of metastasis, 16 had prior chemotherapy and developed chemotherapy-resistant cancers,...
Source: Vaccine Weekly (2009-06-17)
|
